Beckman Daniella 4
4 · Tango Therapeutics, Inc. · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Beckman Daniella
Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-03+26,119→ 158,516 total - Award
Stock Option (Right to Buy)
2025-02-03+156,713→ 156,713 totalExercise: $2.91Exp: 2035-02-03→ Common Stock (156,713 underlying)
Footnotes (2)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 2, 2026, 33% on February 1, 2027 and 34% on February 14, 2028, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F2]This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter.